Eric Richman - Jul 1, 2024 Form 4 Insider Report for Gain Therapeutics, Inc. (GANX)

Role
Director
Signature
/s/ Eric Richman
Stock symbol
GANX
Transactions as of
Jul 1, 2024
Transactions value $
$20,670
Form type
4
Date filed
7/1/2024, 05:00 PM
Previous filing
Jun 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GANX Common Stock Purchase $6.15K +5K +1.83% $1.23* 278K Jul 1, 2024 Direct
transaction GANX Common Stock Purchase $14.5K +12K +4.32% $1.21* 290K Jul 1, 2024 Direct
holding GANX Common Stock 14.8K Jul 1, 2024 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held by the Eric I. Richman Living Trust (the "Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of the shares held by the Trust except to the extent of his proportionate pecuniary interest therein.